Drug Research

Pharma companies in the US have come under fire yet again from the White House. This is the second time in two weeks that such a scenario has taken place. The Biden administration announced that several of drugmakers would...

RSSL, a cutting-edge food and pharmaceutical contract research organisation announced the opening of its new state-of-the-art analytical testing facility on the University of Reading Whiteknights campus, as part of an ambitious expansion plan. The new facility will increase capacity...

Novo Nordisk announced the investment of more than 16 billion Danish kroner (2.1 billion euros) starting in 20231 to expand the existing production site in Chartres, France, for the current and future product portfolio within serious chronic diseases. The investment...

Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), today announced a global licensing and research collaboration with Bristol Myers Squibb focused on the discovery, development and commercialization...

Almac Discovery and Queen’s University Belfast reported a five-year project to develop a new Chemoproteomics Centre of Excellence for drug discovery. The multi-million-pound facility, which is jointly funded by Almac Discovery and a BBSRC Prosperity Partnership award, is a...

Berry Global will demonstrate its commitment to delivering innovative, patient-centric packaging, dispensing solutions, and drug delivery devices for India and the South Asia region on the company’s stand at this year’s CPHI India exhibition. Berry will showcase a wide range...

Myricx Bio, a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads based on N-Myristoyltransferase inhibition (NMTi), and WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development...